Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

HEMACARE CANCELS SALE OF PLASMA CENTERS

Aug. 13, 1991

START-UP PINS HOPES ON MACROPHAGES

Aug. 12, 1991

FINANCIAL BRIEFS

Aug. 12, 1991

GREENWICH PRIVATE PLACEMENT NETS $3.2 MILLION

Aug. 12, 1991

GENEX EXPLAINS PROTEIN G STABILITY

Aug. 12, 1991

TSI PICKS UP ARGUS LABS

Aug. 12, 1991

U.S. BIO ACQUIRES HEXALEN RIGHTS FOR CANADA

Aug. 12, 1991

JOURNAL SCAN

Aug. 12, 1991

APPOINTMENTS AND ADVANCEMENTS

Aug. 12, 1991

INHERITED CANCER GENE ISOLATED

Aug. 9, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...